Related Experiment Video
Updated: Nov 20, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Lung Sestamibi Uptake on Myocardial Perfusion Imaging and Outcomes in Chronic Kidney Disease
Julia Bian1, Charles A Herzog2, Janani Rangaswami3
1University of South Carolina School of Medicine, Columbia, South Carolina, USA.
Insights
In patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD), extreme lung-to-heart ratios (LHR) during cardiac stress testing indicate a higher risk of adverse outcomes. This finding may improve risk stratification in these vulnerable populations.
Area of Science:
- Cardiology
- Nephrology
- Nuclear Medicine
Background:
- Cardiac stress testing has limited accuracy for coronary artery disease in patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD).
- Novel biomarkers derived during stress testing may improve predictive capabilities for cardiovascular events in this population.
Purpose of the Study:
- To evaluate the predictive value of the lung-to-heart ratio (LHR) in patients with CKD and ESKD undergoing cardiac stress testing.
- To determine if LHR can enhance risk assessment for adverse cardiovascular outcomes in CKD and ESKD patients.
Main Methods:
- A retrospective parallel cohort study included 144 CKD not on dialysis (CKD-ND) and 145 ESKD patients who underwent regadenoson sestamibi myocardial perfusion imaging.
- Stress lung-to-heart ratio (LHR) was calculated, and patients were analyzed by LHR tertiles.
- The primary outcome was a composite of all-cause mortality, myocardial infarction, unstable angina, or revascularization.
Main Results:
- Patients with ESKD had a higher comorbidity burden and a higher incidence of identified ischemia compared to CKD-ND patients.
- The primary outcome occurred more frequently in the lowest (LHR ≤0.28) and highest (LHR ≥0.33) LHR tertiles (23% and 33.3%, respectively) compared to the middle tertile (12.8%) (p = 0.005).
- This association between extreme LHR values and adverse outcomes persisted in multivariable analysis and was consistent across both CKD-ND and ESKD groups.
Conclusions:
- Lung-to-heart ratio (LHR) values of ≤0.28 and ≥0.33 are independently associated with an increased risk of mortality in patients with CKD and ESKD.
- Extreme LHR values may serve as an important prognostic indicator in high-risk CKD and ESKD populations.
- Further research is warranted to elucidate the clinical implications of extreme LHR values in these patient groups.
Background And Objectives:
In patients with CKD and end-stage kidney disease (ESKD), cardiac stress testing has low sensitivity and specificity for coronary disease. Alternate markers that are derived during the stress testing may enhance the predictive characteristic of stress testing. The objective was to examine the predictive characteristic of lung-to-heart ratio (LHR) in patients with CKD and ESKD.
Design, Setting, Participants, And Measurements:
Retrospective parallel cohort of ESKD and CKD not on dialysis (CKD-ND) who underwent stress testing with nuclear myocardial perfusion imaging utilizing sestamibi tracer and regadenoson. Stress LHR was calculated by the processing software and reported. Patients were analyzed by tertile of LHR (≤0.28, 0.29-0.32, ≥0.33). The primary outcome was a composite of all-cause mortality, hospitalization for myocardial infarction or unstable angina, or revascularization.
Results:
There were 144 CKD-ND and 145 ESKD patients. Patients with ESKD had greater comorbidity burden than CKD-ND. Stress tests were more often performed for pre-operative risk assessment among ESKD versus CKD-ND (53.8 vs. 5.6%, p < 0.001). ESKD patients more likely had ischemia identified on stress testing (19.3 vs. 8.3%, p = 0.001). Mean LHR was 0.31 (Standard deviation - SD: 0.09) and was similar across CKD-ND stages and ESKD. Primary outcome in the lowest (23%) and highest (33.3%) LHR tertile was higher than the middle tertile (12.8%); p = 0.005. This finding was similar between CKD-ND and ESKD and persisted in multivariable analysis.
Conclusions:
LHR ≤0.28 and ≥0.33 are independently associated with higher risk for death in patients with CKD-ND and ESKD. Future studies are warranted to understand the association of extreme LHR values and outcomes in this high-risk population.
More Related Videos
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Imaging Studies for Cardiovascular System V: CT
Imaging Studies VII: Vascular Imaging
Chronic Kidney Disease III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies